China Resources Medical Holdings Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

China Resources Medical Holdings şirketinin kazançları yıllık ortalama -3.9% oranında azalırken, Healthcare sektörünün kazançları yıllık 11.8% oranında artan oldu. Gelirler yıllık ortalama 36.4% oranında artan oldu. China Resources Medical Holdings şirketinin öz sermaye getirisi 4.7% olup, net marjı 2.9% dir.

Anahtar bilgiler

-3.9%

Kazanç büyüme oranı

-4.1%

EPS büyüme oranı

Healthcare Sektör Büyümesi	11.3%
Gelir büyüme oranı	36.4%
Özkaynak getirisi	4.7%
Net Marj	2.9%
Son Kazanç Güncellemesi	30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

China Resources Medical Holdings nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

SZSC:1515 Gelir, gider ve kazançlar (CNY Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Jun 24	9,970	294	1,069
31 Mar 24	10,039	276	1,061
31 Dec 23	10,108	258	1,053
30 Sep 23	9,958	338	1,025
30 Jun 23	9,809	419	997
31 Mar 23	8,855	342	931
31 Dec 22	7,901	266	864
30 Sep 22	6,891	365	779
30 Jun 22	5,881	463	695
31 Mar 22	5,164	441	630
31 Dec 21	4,447	418	566
30 Sep 21	4,031	410	504
30 Jun 21	3,615	402	441
31 Mar 21	3,183	356	400
31 Dec 20	2,751	310	358
30 Sep 20	2,404	313	306
30 Jun 20	2,058	315	253
31 Mar 20	2,087	353	253
31 Dec 19	2,115	391	254
30 Sep 19	2,112	401	244
30 Jun 19	2,108	412	235
31 Mar 19	2,084	421	229
31 Dec 18	2,059	431	223
30 Sep 18	1,996	364	225
30 Jun 18	1,932	298	227
31 Mar 18	1,905	360	219
31 Dec 17	1,878	421	212
30 Sep 17	1,784	-446	204
30 Jun 17	1,690	-1,312	196
31 Mar 17	1,611	-1,410	184
31 Dec 16	1,533	-1,507	172
30 Sep 16	1,504	-656	167
30 Jun 16	1,475	196	163
31 Mar 16	1,424	181	156
31 Dec 15	1,372	167	150
30 Sep 15	1,337	208	124
30 Jun 15	1,302	249	97
31 Mar 15	1,254	240	91
31 Dec 14	1,206	230	86
30 Sep 14	1,090	176	85
30 Jun 14	975	122	84
31 Mar 14	931	106	79
31 Dec 13	887	90	74

Kaliteli Kazançlar: 1515 büyük bir tek seferlik zarar ile CN¥370.2M, 30th June, 2024 tarihine ait son 12 aylık mali sonuçları etkiliyor.

Büyüyen Kar Marjı: 1515 'nin mevcut net kar marjları (2.9%) geçen yılın (4.3%) değerinden daha düşüktür.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 1515 şirketinin kazançları son 5 yılda yılda 3.9% oranında azaldı.

Büyüme Hızlandırma: 1515 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: 1515 geçtiğimiz yıl negatif kazanç büyümesine ( -29.8% ) sahipti ve bu da onu Healthcare sektör ortalamasıyla ( -16.9% ) karşılaştırmayı zorlaştırıyordu.

Özkaynak Getirisi

Yüksek ROE: 1515 'nin Özsermaye Getirisi ( 4.7% ) düşük olarak değerlendiriliyor.

China Resources Medical Holdings Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

First half 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.32 in 1H 2023)

First half 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.32 in 1H 2023)

China Resources Medical Holdings Company Limited to Report First Half, 2024 Results on Aug 26, 2024

Full year 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.11 in FY 2022)

China Resources Medical Holdings Company Limited to Report Fiscal Year 2023 Results on Mar 19, 2024

First half 2023 earnings released: EPS: CN¥0.32 (vs CN¥0.16 in 1H 2022)

Recent updates

Investor sentiment deteriorates as stock falls 18%

Investor sentiment improves as stock rises 19%

First half 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.32 in 1H 2023)

New minor risk - Profit margin trend

Upcoming dividend of HK$0.055 per share

First half 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.32 in 1H 2023)

China Resources Medical Holdings Company Limited Announces Interim (Semi-Annual) for the Interim Dividend for the Six Months Ended 30 June 2024, Payable on October 25, 2024

China Resources Medical Holdings Company Limited Announces Interim (Semi-Annual) for the Interim Dividend for the Six Months Ended 30 June 2024, Payable on October 25, 2024

China Resources Medical Holdings Company Limited to Report First Half, 2024 Results on Aug 26, 2024

Now 21% undervalued after recent price drop

China Resources Medical Holdings Company Limited Approves the Final Dividend for the Year Ended December 31, 2023, Payable on July 19, 2024

Upcoming dividend of CN¥0.06 per share

Independent Non-Executive Director recently sold HK$2.6m worth of stock

Dividend of CN¥0.06 announced

China Resources Medical Holdings Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 19 July 2024

China Resources Medical Holdings Company Limited, Annual General Meeting, Jun 05, 2024

Full year 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.11 in FY 2022)

Now 24% undervalued after recent price drop

China Resources Medical Holdings Company Limited to Report Fiscal Year 2023 Results on Mar 19, 2024

Now 20% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

China Resources Medical Holdings Company Limited Announces Board and Committee Changes

First half 2023 earnings released: EPS: CN¥0.32 (vs CN¥0.16 in 1H 2022)

China Resources Medical Holdings Company Limited to Report First Half, 2023 Results on Aug 22, 2023

Investor sentiment deteriorates as stock falls 15%

China Resources Medical Holdings Company Limited Announces Board Changes

China Resources Medical Holdings Company Limited Approves Final Dividend for the Year Ended December 31, 2022, Payable on July 19, 2023

Upcoming dividend of HK$0.037 per share at 0.6% yield

Full year 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.33 in FY 2021)

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 18%

China Resources Medical Holdings Company Limited Announces Board Changes

Less than half of directors are independent

First half 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.16 in 1H 2021)

China Resources Medical Holdings Company Limited to Report First Half, 2022 Results on Aug 23, 2022

Investor sentiment improved over the past week

China Resources Medical Holdings Company Limited Declares A Final Dividend for the Year Ended December 31, 2021

China Resources Medical Holdings Company Limited Declares A Final Dividend for the Year Ended December 31, 2021

Upcoming dividend of HK$0.12 per share

Full year 2021 earnings released: EPS: CN¥0.33 (vs CN¥0.25 in FY 2020)

Less than half of directors are independent

China Resources Medical Holdings Company Limited Proposes Final Dividend for Fiscal Year 2021, Payable on or Before July 19, 2022

Investor sentiment improved over the past week

China Resources Medical Holdings Company Limited to Report Fiscal Year 2021 Results on Mar 25, 2022

China Resources Medical Holdings Company Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2021

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.16 (vs CN¥0.086 in 1H 2020)

Non-Executive Director Yan Wang has left the company

Independent Non-Executive Director recently sold HK$4.7m worth of stock

Investor sentiment improved over the past week

Upcoming dividend of HK$0.088 per share

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.31 in FY 2019)

China Resources Medical Holdings Company Limited Proposes Final Dividend for the Year Ended December 31, 2020

Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.31 in FY 2019)

China Resources Medical Holdings Company Limited to Report Fiscal Year 2020 Results on Mar 26, 2021

New 90-day high: HK$7.35

New 90-day high: HK$6.83

New 90-day high: HK$6.00

New 90-day high: HK$5.69

New 90-day low: HK$4.63

First half earnings released

First half earnings released

New 90-day high - HK$5.81

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi